ALEXANDRIA, Va., Oct. 8 -- United States Patent no. 12,433,859, issued on Oct. 7, was assigned to Adalvo Ltd. (San Gwann, Malta).
"Oral solutions comprising lisdexamfetamine salts" was invented by Georgios Liolios (Chalandri Attica, Greece) and Ioannis Psarrakis (Lavrion, Greece).
According to the abstract* released by the U.S. Patent & Trademark Office: "Oral pharmaceutical solution comprising a pharmaceutically acceptable salt of lisdexamfetamine, and a pharmaceutically acceptable aqueous carrier comprising a buffer and a cosolvent selected from the group consisting of a glycol, a polyol, and a mixture thereof, wherein the pH of the solution is from 5.5 to 9.0. The oral pharmaceutical solution presents excellent physicochemical stabilit...